WAT Medical Enterprise Ltd., a name synonymous with advanced healthcare technologies, has announced the upcoming launch of its latest creation, the EmeTerm Smart – a pioneering device that promises to blend the benefits of an anti-nausea wristband with the convenience and features of a smartwatch. Set to make its debut through the crowdfunding platform Indiegogo, this device is being hailed as the first of its kind in the world.
Drawing from a poignant personal experience, the founder of WAT Medical was propelled to innovate a solution when his wife suffered from intense morning sickness. This quest for a drug-free therapeutic alternative led to the birth of WAT Medical in 2015, a company grounded in the ethos of integrating cutting-edge health technology with patient-focused care.
Over the years, WAT Medical has carved a niche in the development of precision-based, wearable medical devices aimed at managing and preventing conditions such as nausea, migraines, and obesity. Driven by professionals like co-founder Peter Ji, a Doctorate holder from the University of California, Berkeley, the team at WAT Medical has always prioritized making meaningful strides in the global healthcare arena.
EmeTerm Smart, the newest addition to WAT Medical’s product portfolio, represents a milestone in the brand’s journey. It leverages transcutaneous electrical nerve stimulation (TENS), a scientifically-endorsed approach that activates specific nerve pathways to reduce feelings of nausea without relying on pharmaceuticals. Proudly carrying FDA approval and a success rate of up to 85%, EmeTerm Smart is a testament to the brand’s commitment to safe and natural healthcare solutions.
Notably, research featured in the British Journal of Anesthesia has corroborated the effectiveness of TENS wristbands in preventing postoperative nausea and vomiting. Ohio State University further strengthened these claims with a study completed on February 27, 2023, offering concrete validation through patient feedback and physiological measures.
But EmeTerm Smart isn’t just about combating nausea. It is also designed with an array of smartwatch functionalities, including a touch-sensitive screen for adjusting stimulation levels, timekeeping abilities, as well as a step counter to promote a proactive approach to health monitoring. With an IP67 waterproof rating, it also promises versatility and resilience, perfectly suitable for wear during a variety of activities.
The much-anticipated EmeTerm Smart is slated for release on Indiegogo in August 2024, carrying a suggested retail price of $299. However, early adopters can take delight in exclusive discounts of up to 39% off the original price.
Eager potential users and health enthusiasts are encouraged to stay tuned for the Indiegogo campaign to gain early access to this groundbreaking device, destined to empower individuals in their quest for a healthier, nausea-free lifestyle.
